Elanco Animal Health Statistics
Total Valuation
ELAN has a market cap or net worth of $12.07 billion. The enterprise value is $15.94 billion.
| Market Cap | 12.07B |
| Enterprise Value | 15.94B |
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELAN has 499.45 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 499.45M |
| Shares Outstanding | 499.45M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +1.83% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 110.02% |
| Float | 494.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.61 |
| PS Ratio | 2.47 |
| Forward PS | 2.36 |
| PB Ratio | 1.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 38.32 |
| P/OCF Ratio | 20.92 |
| PEG Ratio | 1.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.44, with an EV/FCF ratio of 50.61.
| EV / Earnings | n/a |
| EV / Sales | 3.26 |
| EV / EBITDA | 16.44 |
| EV / EBIT | 51.93 |
| EV / FCF | 50.61 |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.16 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 4.12 |
| Debt / FCF | 13.65 |
| Interest Coverage | 1.17 |
Financial Efficiency
Return on equity (ROE) is -3.77% and return on invested capital (ROIC) is 2.95%.
| Return on Equity (ROE) | -3.77% |
| Return on Assets (ROA) | 1.47% |
| Return on Invested Capital (ROIC) | 2.95% |
| Return on Capital Employed (ROCE) | 2.66% |
| Weighted Average Cost of Capital (WACC) | 11.28% |
| Revenue Per Employee | $494,242 |
| Profits Per Employee | -$24,444 |
| Employee Count | 9,900 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, ELAN has paid $45.00 million in taxes.
| Income Tax | 45.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.38% in the last 52 weeks. The beta is 1.70, so ELAN's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | +69.38% |
| 50-Day Moving Average | 22.90 |
| 200-Day Moving Average | 22.50 |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 6,548,980 |
Short Selling Information
The latest short interest is 33.15 million, so 6.64% of the outstanding shares have been sold short.
| Short Interest | 33.15M |
| Short Previous Month | 24.34M |
| Short % of Shares Out | 6.64% |
| Short % of Float | 6.70% |
| Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, ELAN had revenue of $4.89 billion and -$242.00 million in losses. Loss per share was -$0.49.
| Revenue | 4.89B |
| Gross Profit | 2.69B |
| Operating Income | 307.00M |
| Pretax Income | -197.00M |
| Net Income | -242.00M |
| EBITDA | 970.00M |
| EBIT | 307.00M |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $428.00 million in cash and $4.30 billion in debt, with a net cash position of -$3.87 billion or -$7.75 per share.
| Cash & Cash Equivalents | 428.00M |
| Total Debt | 4.30B |
| Net Cash | -3.87B |
| Net Cash Per Share | -$7.75 |
| Equity (Book Value) | 6.50B |
| Book Value Per Share | 13.02 |
| Working Capital | 1.92B |
Cash Flow
In the last 12 months, operating cash flow was $577.00 million and capital expenditures -$262.00 million, giving a free cash flow of $315.00 million.
| Operating Cash Flow | 577.00M |
| Capital Expenditures | -262.00M |
| Depreciation & Amortization | 663.00M |
| Net Borrowing | -361.00M |
| Free Cash Flow | 315.00M |
| FCF Per Share | $0.63 |
Margins
Gross margin is 55.06%, with operating and profit margins of 6.27% and -4.95%.
| Gross Margin | 55.06% |
| Operating Margin | 6.27% |
| Pretax Margin | -4.03% |
| Profit Margin | -4.95% |
| EBITDA Margin | 19.82% |
| EBIT Margin | 6.27% |
| FCF Margin | 6.44% |
Dividends & Yields
ELAN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.21% |
| Shareholder Yield | 0.21% |
| Earnings Yield | -2.00% |
| FCF Yield | 2.61% |
Analyst Forecast
The average price target for ELAN is $29.79, which is 23.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.79 |
| Price Target Difference | 23.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 5.75% |
| EPS Growth Forecast (3Y) | 12.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ELAN has an Altman Z-Score of 1.22 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.22 |
| Piotroski F-Score | 6 |